Top NYC, NY App Development Companies With Best Stability & Growth (112)

Strong Revenue Growth: Revenue is expanding at strong double‑digit rates across recent quarters and the latest fiscal year, with cloud revenue and ARR also rising. Investor materials and quarterly updates highlight consistent momentum rather than a one‑off spike.

Strong Market Position & Advantage: Independent analyst recognitions position the company as a Leader across multiple core categories, and it serves a very large, global customer base including much of the Fortune 500. This broad market presence supports pricing power, cross‑sell, and durable demand.

Innovation-Driven Growth: Cloud migrations and newly introduced AI capabilities are cited as meaningful tailwinds for adoption and expansion. Product enhancements and platform integrations are associated with larger enterprise deals and a growing backlog of committed revenue.

Market Expansion: The relocation of global headquarters to Austin, where the workforce concentration is highest, points to expansion of the company’s geographic footprint. References to Austin as the largest office and a presence across 16 locations worldwide reinforce an active scaling and reorientation.

Innovation-Driven Growth: Recent launches such as Bruce ATS and the Austin-based PEAK6 Trials founder residency demonstrate ongoing creation of new products and ventures. Continued capital deployment into areas like robotics (e.g., follow-on investment in Apptronik) underscores an innovation-led growth approach.

Strategic Partnerships: Partnerships across the ecosystem—such as Apex Fintech Solutions’ tie-up with State Street and Navy Federal Investment Services—highlight growth through alliances. A Nasdaq data partnership supporting Bruce further signals expansion via external collaborations.

Strong Revenue Growth: Revenue is consistently rising at double-digit rates, including about 26% growth in 2025 and 22%–28% year-over-year gains across early 2026. Company disclosures also highlight increasing payers and monetization, reinforcing the revenue trajectory.

Market Expansion: International rollout accelerated across Europe and Latin America in 2025–2026, with entries into additional countries and leadership in downloads across several expansion markets. European expansion-market revenue rose sharply year over year, evidencing traction beyond core English-speaking geographies.

Strong Market Position & Advantage: The app maintains a top-tier standing among dating platforms, including #1 download positions in select European markets and a top-three rank in the U.S. Consistent MAU and payer growth alongside high download ranks indicate strengthening competitive footing.

Strong Market Position & Advantage: KUBRA is described as a leading provider of bill payment and customer communications, serving 250+ enterprise clients and reaching a large share of U.S. and Canadian households. Acquisition materials emphasize entrenched relationships and vertical leadership in utilities and adjacent regulated sectors.

Profitability: Financial disclosures indicate meaningful adjusted EBITDA in 2025 and positive net income in early 2026, pointing to an established, profitable operation. Guidance also calls for a substantial EBITDA contribution in the months following the acquisition.

Resilient & Sustainable Growth: Reported revenue growth has been mid-single-digit historically with continued year-over-year expansion immediately post-acquisition. Management highlights recurring payment flows and opportunities to deepen penetration with existing and combined clients.

Investor Backing & Capital Strength: Recent financing includes a $50 million Series D anchored by Boehringer Ingelheim, following a Series C in 2025 and prior debt financing, indicating sustained access to strategic capital. The transfer of CT-155 commercialization responsibility alongside dedicated commercial funding further underscores capital support aligned with near-term growth plans.

Strategic Partnerships: Collaborations with major pharmaceutical companies such as Otsuka and Boehringer Ingelheim, alongside agreements with Indivior and Ultrahuman, reflect deepening partner engagement in development and commercialization. These alliances have produced FDA-authorized products and structured milestone and royalty pathways that reinforce external validation.

Product Line Growth: Multiple FDA authorizations (Rejoyn for MDD and CT-132 for migraine), the acquisition of AspyreRx, and an expanded pipeline spanning psychiatry, neurology, and cardiometabolic disease point to a broader, more mature portfolio. Positive Phase 3 results and commercialization preparations for CT-155 add momentum to this expansion.

Investor Backing & Capital Strength: New capital in July 2026—$10M of a planned larger round with an SEC Form D filing—signals renewed financial support, with cumulative funding reported around $52.9M. This underpins ongoing rebuild and expansion efforts.

Market Expansion: Operations span Florida, Ohio, Michigan, Virginia, and Washington, with multiple local offices indicating a substantial multi-state footprint. Reported coverage of 45,000 attributed lives across multiple states points to meaningful scale in these markets.

Strong Hiring & Retention: Company materials and LinkedIn indicate a 201–500 employee range with active recruiting, including peer-support roles. Hiring activity in 2026 aligns with expansion across several states.

Strong Revenue Growth: Revenue increased year over year in the latest quarters, with momentum accelerating into Q2 2026. Monetization per user improved, helping top-line growth outpace audience expansion.

Healthy Cash Flow: Adjusted EBITDA and free cash flow rose sharply, and the company generated positive free cash flow in the latest quarter. These gains indicate stronger operating leverage versus a year earlier.

Diversified Revenue Streams: Subscription and other direct-revenue products such as Snapchat+ expanded rapidly alongside core advertising. “Other revenue” grew significantly and the direct-revenue run rate scaled materially.

Profitability: Profitability is depicted as strong, with non-GAAP operating margins near 40% and improved GAAP net income. Feedback suggests this strength persists even amid slow top-line growth.

Healthy Cash Flow: Cash generation is highlighted as substantial, including FY2025 free cash flow above $1B and significant unlevered free cash flow in Q2 2026. Feedback suggests robust cash flow supports buybacks and financial flexibility.

Resilient & Sustainable Growth: Core operations are portrayed as stabilizing in 2026 with low single-digit revenue and ARR growth excluding FormSwift. Feedback suggests paying users have resumed modest sequential increases, indicating resilience.

Strong Revenue Growth: Recent results show Peacock revenue up 54% year over year to $1.90 billion, Studios up 25% to about $3 billion, and NBCUniversal media and theme-park revenue up 23% to $10.7 billion in Q2 2026. Earlier in 2026, the parks business also rose 24% on the launch of Epic Universe.

Profitability: Peacock reached a key inflection with its first quarterly pre-tax profit of $189 million alongside paid subscribers rising to 48 million in Q2 2026. This points to improving streaming economics within the portfolio.

Future-Ready Strategy: Management is reshaping the portfolio by planning to spin off NBCUniversal and Sky into a standalone public company positioned to pursue growth across parks, film/TV, streaming, sports and news. The 2025 shareholder letter also highlights studios, streaming and parks as principal growth drivers representing a large share of Comcast’s revenue.